Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)

30. november 2018 opdateret af: Pfizer
Serotype distribution and estimation of antimicrobial resistance in S. pneumoniae isolates and anticipated PCV7 and PCV13 coverage is difficult in Greece, because invasive isolates collected each year are limited and depict a certain proportion of patients who have easy access to tertiary care or have underlying medical reasons which necessitate inpatient care. It is also probable that the real burden of pneumococcal disease is not well estimated especially among adults. New additions in the laboratory setting such as the pneumococcal urine antigen assay (Binax NOW®) and the Urinary Antigen Diagnostic Assay (Luminex) for the detection of 13 serotype specific polysaccharides in human urine developed by Pfizer might be helpful in identifying more pneumococcal infections compared to the previous years. This NIS is based on the unmet scientific need to describe the serotype distribution and the resistance profile of isolates from X-Ray confirmed CAP in the present circumstances.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

For each surveillance period lasting for 12 months all adults presenting in the selected clinics with symptoms and signs suggestive of pneumonia (candidate cases) will be asked to participate in the study

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

293

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Alexandroupoli, Grækenland, 68100
        • General University Hospital of Alexandroupoli
      • Athens, Grækenland, 11527
        • General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
      • Athens, Grækenland, 11527
        • General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
      • Athens, Grækenland, 15123
        • Diagnostic Therapeutic Center of Athens Ygeia
      • Athens, Grækenland, 15126
        • General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
      • Athens, Grækenland, 15126
        • General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
      • Athens, Grækenland, 15126
        • General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
      • Athens, Grækenland, 15127
        • General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
      • Athens, Grækenland, 15127
        • General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
      • Athens, Grækenland, 15227
        • Sotiria Hospital, Intensive Care Unit
      • Athnens, Grækenland
        • General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
      • Kavala, Grækenland, 65201
        • General Hospital of Kavala/ A Pneumonological Clinic
      • Kavala, Grækenland, 65201
        • General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
      • Larissa, Grækenland, 41 110
        • University General Hospial of Larissa, Pneumonology Department
    • Attiki
      • Athens, Attiki, Grækenland
        • General Hospital of Athens "Evangelismos" / Pneumonology Department
    • Evros
      • Alexandroupoli, Evros, Grækenland, 68100
        • University Hospital of Alexandroupolis

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Adults ≥18 years of age with chest X-ray confirmed CAP

Beskrivelse

Inclusion Criteria:

  • Patients who agreed to participate in the study and agreed to sign an ICD.
  • Patients had to be ≥18 years of age (adults)
  • Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
  • Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
  • Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)

Exclusion Criteria:

  • Patients who did not sign an ICD.
  • Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
  • Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
  • Patients who did not have a chest X-ray performed
  • Patients who did not have the Binax NOW® assay performed
  • Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: Kun etui
  • Tidsperspektiver: Fremadrettet

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
This Is A Non Interventional Study

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Tidsramme: One year
One year
calendar year.
Tidsramme: One year
One year

Sekundære resultatmål

Resultatmål
Tidsramme
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Tidsramme: One year
One year
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Tidsramme: One year
One year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. januar 2011

Primær færdiggørelse (Faktiske)

1. april 2013

Studieafslutning (Faktiske)

1. april 2013

Datoer for studieregistrering

Først indsendt

26. marts 2012

Først indsendt, der opfyldte QC-kriterier

27. marts 2012

Først opslået (Skøn)

28. marts 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. december 2018

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. november 2018

Sidst verificeret

1. november 2018

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • B1851065

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .